Literature DB >> 8707986

Host response assessment in recurring periodontitis.

J L Ebersole1, D Cappelli, M J Steffen, D E Willmann, D S O'Dell.   

Abstract

Data derived from periodontitis patients have provided support for a relationship between the distribution of selected members of the periodontopathic microbiota and antibody levels to the intact bacteria in both serum and GCF. These data are consistent with the systemic antibody as a reflection of the host response to an infectious process associated with an episode of disease activity. The purpose of this report is to address the concept that the host antibody responses may help to elucidate the specific etiologic agents and be used to model the risk for future periodontal disease progression in recurring periodontitis. These findings from one study in adult periodontitis patients indicated that elevations in certain antibody specificities are most closely associated with patients exhibiting a risk of disease recurrence. Furthermore, analysis of the frequency of antibody elevations suggested that patients capable of maintaining elevated antibody to these pathogens post-treatment, may be indicative of an individual at less risk. A 2nd investigation was implemented to address questions concerning host-parasite interactions in A. actinomycetemcomitans-associated recurring periodontitis. The results showed distinctive characteristics of local and systemic antibody responses and A. actinomycetemcomitans infection in patients with varying extents of recurrent disease. These longitudinal studies developed evidence for the potential of local and/or systemic antibody responses as indicators of periodontal disease recurrence.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707986     DOI: 10.1111/j.1600-051x.1996.tb02085.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  8 in total

1.  Periodontitis in pregnancy: clinical and serum antibody observations from a baboon model of ligature-induced disease.

Authors:  D Cappelli; M J Steffen; S C Holt; J L Ebersole
Journal:  J Periodontol       Date:  2009-07       Impact factor: 6.993

Review 2.  Multispecies biofilms and host responses: "discriminating the trees from the forest".

Authors:  R Peyyala; J L Ebersole
Journal:  Cytokine       Date:  2012-11-06       Impact factor: 3.861

3.  Characterization of heat-inducible expression and cloning of HtpG (Hsp90 homologue) of Porphyromonas gingivalis.

Authors:  D E Lopatin; A Combs; D G Sweier; J C Fenno; S Dhamija
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

4.  Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease.

Authors:  Pamela Sparks Stein; Michelle J Steffen; Charles Smith; Gregory Jicha; Jeffrey L Ebersole; Erin Abner; Dolph Dawson
Journal:  Alzheimers Dement       Date:  2012-05       Impact factor: 21.566

5.  Polybacterial challenge effects on cytokine/chemokine production by macrophages and dendritic cells.

Authors:  C B Huang; Y Altimova; S Strange; J L Ebersole
Journal:  Inflamm Res       Date:  2010-08-27       Impact factor: 4.575

6.  Differential gender effects of a reduced-calorie diet on systemic inflammatory and immune parameters in nonhuman primates.

Authors:  J L Ebersole; M J Steffen; M A Reynolds; G L Branch-Mays; D R Dawson; K F Novak; J C Gunsolley; J A Mattison; D K Ingram; M J Novak
Journal:  J Periodontal Res       Date:  2008-06-28       Impact factor: 4.419

7.  Tracking of plasma antibodies against Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis during 15 years.

Authors:  Laura Lakio; Johanna Antinheimo; Susanna Paju; Kåre Buhlin; Pirkko J Pussinen; Georg Alfthan
Journal:  J Oral Microbiol       Date:  2009-08-03       Impact factor: 5.474

8.  Immune Response to Enterococcus gallinarum in Lupus Patients Is Associated With a Subset of Lupus-Associated Autoantibodies.

Authors:  Harini Bagavant; Antonina M Araszkiewicz; Jessica K Ingram; Katarzyna Cizio; Joan T Merrill; Cristina Arriens; Joel M Guthridge; Judith A James; Umesh S Deshmukh
Journal:  Front Immunol       Date:  2021-05-28       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.